BioSpace News Archive

Genetown

Posting of Annual Report and Notice of AGM

Amryt announces that copies of the Company’s annual report for the year ended December 31, 2021 have been sent to Shareholders along with the Notice of Annual General Meeting.

June 1, 2022
·
6 min read
Biotech Beach

Zentalis Pharmaceuticals to Participate in the Jefferies Healthcare Conference - June 01, 2022

Zentalis Pharmaceuticals, Inc. announced that Kimberly Blackwell, MD, Chief Executive Officer of Zentalis, and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 11:30 a.m. ET.

June 1, 2022
·
4 min read
Drug Development

Talaris Therapeutics Announces Conference Call to Highlight Presentations at the American Transplant Congress (ATC) and Provide a Data Update from its Phase 3 FREEDOM-1 Study

Talaris Therapeutics, Inc. announced it will host a conference call to discuss its presentations at the American Transplant Congress and provide a data update from its ongoing Phase 3 FREEDOM-1 study in living donor kidney transplant recipients.

June 1, 2022
·
1 min read
Pharm Country

Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®

Helius Medical Technologies, Inc. announced the launch of its Patient Therapy Access Program, which will provide qualifying patients access to on-label Portable Neuromodulation Stimulator Therapy at a significantly reduced price.

June 1, 2022
·
5 min read
BioMidwest

Six Things People Living with Alzheimer’s Disease and Other Dementia Want You to Know

Many Americans struggle with what to say and do when a family member, friend, co-worker or neighbor is diagnosed with Alzheimer’s disease or another dementia.

June 1, 2022
·
5 min read
Drug Development

Amolyt Pharma Announces Positive Results from First Patient Cohort of Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism

Amolyt Pharma announced positive results from the first cohort of its clinical proof of concept trial of AZP-3601, which the company is developing as a potential treatment for hypoparathyroidism.

June 1, 2022
·
5 min read
Genetown

Vor Bio to Participate in Upcoming Investor Conferences - June 01, 2022

Vor Bio, a clinical-stage cell and genome engineering company, announced that it will participate in the following upcoming investor conferences.

June 1, 2022
·
1 min read
Biotech Beach

Ventyx Biosciences to Participate in the Jefferies Healthcare Conference - June 01, 2022

Ventyx Biosciences, Inc. announced that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview during a fireside chat at the Jefferies Healthcare Conference being held June 8-10, 2022.

June 1, 2022
·
1 min read
Business

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer, announced financial results for the first quarter ended March 31, 2022.

June 1, 2022
·
11 min read
Genetown

Chiesi Global Rare Diseases Announces Support for Jeffrey Modell Foundation’s Global Genetic Sequencing Initiative “Jeffrey’s Insights”

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research focused healthcare Group, announced that it is joining with other pharmaceutical companies to support the Jeffrey Modell Foundation’s initiative, “Jeffrey’s Insights,” a global genetic sequencing program.

June 1, 2022
·
5 min read